Manufacture of Recombinant Biopharmaceutical Proteins by Cultivated Mammalian Cells in Bioreactors

Modern Biopharmaceuticals: Design, Development and Optimization

Volumn 3, Issue , 2008, Pages 723-759

  Wurm, Florian M ^a  

^a EPFL   (Switzerland)

Author keywords

Bioreactors; Electroporation; Hygromycin; Jeopardizing; Linearization

Indexed keywords

EID: 84889979454     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527620982.ch31     Document Type: Chapter

References (152)

1. Andersen, D. (2004) Scientific report at a cell culture conference in Cancun.
2. Kao, F.-T., Puck, T.T. (1968) Genetics of somatic mammalian cells VII. Induction and isolation of nutritional mutants in Chinese hamster cells. Proc. Natl. Acad. Sci. USA 60:1275-1281.
3. Puck, T.T. (1985) Development of the Chinese hamster ovary (CHO) cell for use in somatic cell genetics. In: M.M. Gottesman (Ed) Molecular Cell Genetics, John Wiley & Sons, New York, pp. 37-64.
4. Urlaub, G. and Chasin, L. A. (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci. USA 77:4216-4220.
5. Ringold, G., Dieckmann, B., and Lee, F. (1981) Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells. J. Mol. Appl. Genet. 1:165-175.
6. Kaufman, R. J. and Sharp, P. (1982) Amplification and Expression of Sequences Cotransfected with a Modular Dihydrofolate Reductase Complementary DNA Gene. J. Mol. Biol. 159:601-621.
7. Kaufman, R. J., Wasley, L. C., Spiliotes, A. J., Gossels, S. D., Latt, S. A., Larsen, G.R., and Kay, R.M. (1985) Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase in Chinese hamster ovary cells. Mol. Cell. Biol. 5:1750-1759.
8. Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H.L., Goeddel, D.V., and Collen, D. (1983) Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301:214-221.
9. Gottesman, M.M. (1985) Molecular Genetics. John Wiley & Sons, New York.
10. Graham, F. L. and van der Eb, A. J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
11. Wigler, M., Silverstein, S., Lee, L.-S., Pellicer, A., Cheng, Y.-C., and Axel, R. (1977) Transfer of purified Herpes Virus thymidine kinase gene to cultured cells. Cell 11:223-232.
12. Pellicer, A., Wigler, M., and Axel, R. (1978) The transfer and stable integration of the HSV thymidine kinase gene into mouse cells. Cell 14:133-141.
13. Robins, D.M., Ripley, S., Henderson, A., and Axel, R. (1981) Transforming DNA integrates into the host chromosome. Cell 23:29-39.
14. Chen, C. and Okayama, H. (1987) High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 8:2745-2752.
15. Jordan, M., Schallhorn, A. and Wurm, F.M. (1996) Transfecting mammalian cells: optimization of critical parameters affecting calciumphosphate precipitate formation. Nucleic Acids Res. 24, 4:596-601.
16. Jordan M., Köhne, C. and Wurm, F.M. (1997) Principles of a scaleable transient transfection and expression technology for mammalian cells. In: M.J. Carrondo, B. Griffiths and J. P. Moreira (Eds) Animal Cell Technology-from Vaccines to Genetic Medicine, pp. 47-50. Kluwer Academic Publishers.
17. Finn, G. K., Kurz, B.W., Cheng, R. Z. and Shmookler, R. J. (1989) Homologous plasmid recombination is elevated in immortally transformed cells. Mol. Cell. Biol. 9:4009-4017.
18. Grosjean, F., Batard, P., Jordan, M. and Wurm, F.M. (2002) S-phase synchronized CHO cells show elevated transfection efficiency and expression using CaPi. Cytotechnology 38, 1/2:57-62.
19. Mansour, S. L., Thomas, K. R., and Capecchi, M.R. (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352.
20. Zheng, H. and Wilson, J.H. (1990) Gene targeting in normal and amplified cell lines. Nature 344:170-173.
21. Wurm, F. M., Johnson, A., Ryll, T., Köhne, C., Scherthan, H., Glaab, F., Lie, Y. S., Petropoulos, C. J. and Arathoon, W.R. (1996) Gene transfer and amplification in CHO cells-efficient methods for maximising specific productivity and assessment of genetic consequences. Ann. N.Y. Acad. Sci. 782:70-78.
22. Perucho, M., Hanahan, D., and Wigler, M. (1980) Genetic and physical linkage of exogenous sequences in transformed cells. Cell 22:309-317.
23. Finn, G. K., Kurz, B.W., Cheng, R. Z., and Shmookler Reis, R. J. (1989) Homologous Plasmid Recombination is Elevated in Immortally Transformed Cells. Mol. Cell. Biol. 9, 9:4009-4017.
24. Folger, K. R., Wong, E. A., Wahl, G., and Capecchi, M.R. (1982) Patterns of integration of DNA microinjected into cultured mammalian cells: evidence for homologous recombination between injected plasmid molecules. Mol. Cell. Biol. 2, 11:1372-1387.
25. Jordan, M. and Wurm, F.M. (2003) Co-transfer of multiple plasmids/viruses as an attractive method to introduce several genes in mammalian cells. In: S. C. Makrides (Ed.) Gene Transfer and Expression in Mammalian Cells. New Comprehensive Biochemistry, Volume 38, pp. 337-357.
26. Chen, L., Marmey, P., Taylor, N. J., Brizard, J.-P., Espinoza, C., D'Cruz, P., Huet, H., Zhang, S., Kochko, A., de Beachy, R. N., and Fauquet, C.M. (1998) Expression and inheritance of multiple transgenes in rice plants. Nature Biotechnol. 16:1060-1064.
27. Wurm, F.M. (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology 22, 11:1393-1398.
28. Wurm, F. M., Johnson, A., Lie, Y. S., Etcheverry M.T., and Anderson, K. P. (1992) Host Cell Derived Retroviral Sequences Enhance Transfection and Expression Efficiency in CHO Cells. In: Spier, R. E., Griffiths, J. B., Mac-Donald, C. (Eds) Animal Cell Technology: Developments, Processes and Products. Butterworth-Heinemann, Oxford, UK, pp. 35-41.
29. Barnes, L. M., Bentley, C. M., and Dickson, A. J. (2004) Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells. Biotechnol. Bioeng. 85:115-121.
30. Jones, D., Kroos, N., Anema, R., von Montfort, B., Vooys, A., van der Kraats, S., van der Helm, E., Smits, S., Schouten, J., Brouwer, K., Lagerwerf, F., van Berkel, P., Opstelten, D.-J., Logtenberg, T., and Bout, A. (2003) High level expression of recombinant IgG in the human cell line PER.C6. Biotechnol. Prog. 19:163-168.
31. Chu, G., Hayakawa, H., and Berg, P. (1987) Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res. 15:1311-1326.
32. Barsoum, J. (1990) Introduction of stable high-copy-number DNA into Chinese hamster ovary cells by electroporation. DNA Cell Biol. 9, 4:293-300.
33. Felgner, P.L. and Ringold, G.M. (1989) Cationic liposome-mediated transfection. Nature 337:387-388.
34. Behr, J.-P., Demeneix, B., Loeffler, J.-P., and Perez-Mutul, J. (1989) Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. USA 86:6983-6986.
35. Muller, S. R., Sullivan, P. D., Clegg, D.O., and Feinstein, S.C. (1990) Efficient transfection and expression of heterologous genes in PC12 cells. DNA Cell Biol. 9, 3:221-229.
36. O'Brien, J. and Lummis, S. C. R. (2004) Biolistic and diolistic transfection: using the gene gun to deliver DNA and lipophilic dyes into mammalian cells. Methods 33:121-125.
37. Brokx, R. and Gariepy, J. (2004) Peptide-and polymer-based gene delivery vehicles. Methods Mol. Med. 90:139-160.
38. Putnam, D., Gentry, C. A., Pack, D.W., and Langer, R. (2001) Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc. Natl. Acad. Sci. USA 98(3):1200-1205.
39. Jasin, M. and Berg, P. (1988) Homologous integration in mammalian cells without target gene selection. Genes Dev. 2:1353-1363.
40. Smithies, O., Gregg, R. G., Boggs, S. S., Koralewski, M.A., and Kucherlapati, R.S. (1985) Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317:230-234.
41. Bode, J., Benham, C., Ernst, E., Knopp, A., Marschalek, R., Strick, R., and Strissel, P. (2000) Fatal connections: when DNA ends meet on the nuclear matrix. J. Cell Biochem. 35:3-22.
42. Bode, J., Götze, S., Ernst, E., Hüsemann, Y., Baer, A., Seibler, J., and Mielke, C. (2002) Architecture and utilization of highly expressed genomic sites. In: S. C. Makrides (Ed) Gene transfer and expression in mammalian cells. Elsevier Science B.V., pp. 551-571.
43. Wilson, T.J. and Kola, I. (2001) The LoxP/CRE system and genome modification. Methods Mol. Biol. 158:83-94.
44. Gopalkrishnan, R.V., Christiansen, K. A., Goldstein, N. I., DePinho, R. A., and Fisher, P. B. (1999) Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res. 27(24):4775-4782.
45. Kim, S.Y., Lee, J. H., Shin, H.S., Kang, H.J., and Kim, Y. S. (2002) The human elongation factor 1 alpha (EF-1 alpha) first intron highly enhances expression of foreign genes from the murine cytomegalovirus promoter. J. Biotechnol. 93:183-187.
46. Wilson, J. H., Berget, P. B., and Pipas, J.M. (1982) Somatic cells efficiently join unrelated DNA segments end to end. Mol. Cell. Biol. 2:1258-1269.
47. Balland, A., Faure, T., Carvallo, D., Cordier, P., Ulrich, P., Fournet, B., de la Salle, H., and Lecocq, J. P. (1988) Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vector. Eur. J. Biochem. 172(3):565-572.
48. Meents, H., Enenkel, B., Werner, R.G. and Fussenegger, M. (2002) p 27Kip1-mediated controlled proliferation technology increases constitutive sICAM production in CHODUKX adapted for growth in suspension and serum-free media. Biotechnol. Bioeng. 79, 6:619-627.
49. Kaufmann, H. and Fussenegger, M. (2003) Metabolic engineering of mammalian cells for higher protein yield. In: S.C. Makrides (Ed) Gene transfer and expression in mammalian cells. Elsevier Science B.V., pp. 547-569.
50. Wurm, F. M., Gwinn, K. A., and Kingston, R. E. (1986) Inducible overexpression of the mouse c-myc protein in mammalian cells. Proc. Natl. Acad. Sci. USA 83:5414-5418.
51. Weber, W., Fux, C., Daoud-El Baba, M., Keller, B., Weber, C. C., Kramer, B. P., Heinzen, C., Aubel, D., Bailey, J. E., and Fussenegger, M. (2002) Macrolide-based transgene control in mammalian cells and mice. Nature Biotechnol. 20:901-907.
52. Richards, E. J. and Elgin, S. C. (2002) Epigenetic codes for heterochromatin formation and silencing: rounding up of the usual suspects. Cell 108:489-500.
53. Girod, P.-A. and Mermod, N. (2003) Use of scaffold/matrix-attachment regions for protein production. In: S. C. Makrides (Ed) Gene transfer and expression in mammalian cells. Elsevier Science B.V., pp. 359-379.
54. Antoniou, M., Harland, L., Mustoe, T., Williams, S., Holdstock, J., Yague, E., Mulcahy, T., Griffiths, M., Edwards, S., Ioannou, P. A., Mountain, A., and Crombie, R. (2003) Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82(3):269-279.
55. Stief, A., Winter, D. M., Stratling, W. H., and Sippel, A. E. (1989) A nuclear attachment element mediates elevated and position-independent gene activity. Nature 341:343-345.
56. Phi-Van, L., von Kries, J. P., Ostertag, W., and Stratling, W.H. (1990) The chicken lysozyme 5' matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens position effects on the expression of transfected genes. Mol. Cell. Biol. 10:2302-2307.
57. Martens, J. H., Verlaan, M., Kalkhoven, E., Dorsman, J. C., and Zantema, A. (2002) Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes. Mol. Cell. Biol. 22:2598-2606.
58. Fernandez, L. A., Winkler, M., and Grosschell, R. (2001) Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol. Cell. Biol. 21:196-208.
59. Zahn-Zabal, M., Kobr, M., Imhof, M.O., Chatellard, P., de Jesus, M., Wurm, F., and Mermod, N. (2001) Development of stable cell lines for production or regulated expression using matrix attachment regions. J. Biotechnol. 87:29-42.
60. Kwaks, T.H.J., Barnett, P., Hemrika, W., Siersma, T., Sewalt, R.G. A. B., Satijn, D. P. E., Brons, J. F., van Blokland, R., Kwakman, P., Kruckeberg, A. L., Kelder, A. and Otte, A. P. (2003) Identification of anti-repressor elements that confer high and stable protein production in mammalian cells. Nature Biotechnol. 21:553-558.
61. Mutskov, V. and Felsenfeld, G. (2004) Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine. EMBO J. 23:138-149.
62. Hacker, D. L., Derow E. and Wurm, F.M. (2005) The CELO Adenovirus Gam1 Protein Enhances Transient and Stable Recombinant Protein Expression in Chinese Hamster Ovary Cells. J. Biotechnology 117:21-29.
63. Gorman, C. M., Howard, B. H., and Reeves, R. (1983) Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res. 11:7631-7648.
64. Riggs, M.G., Whittaker, R. G., Nuemann, J. R., and Ingram, V.M. (1977) n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268:462-464.
65. Cuisset, L., Tichonicky, L., and Delpech, M. (1998) A protein phosphatase is involved in the inhibition of histone diacetylation by sodium butyrate. Biochem. Biophys. Res. Commun. 246:760-764.
66. Makrides, S. C. (1999) Components of vectors for gene transfer and expression in mammalian cells. Protein Express. Purif. 17:183-202.
67. Shirahata, S., Teruya, K., Seki, K., Mori, T., Ohashi, H., Tachibana, H., and Murakami, H. (1992) Oncogene-activated production of recombinant proteins for animal cells. In: Spier, R.E., Griffiths, J.B., MacDonald, C. (Eds) Animal Cell Technology: Developments, Processes and Products. Butterworth-Heinemann, Oxford, pp. 54-59.
68. Lee, K. H., Guerini-Sburlati, A., Renner, W. A., and Bailey, J.E. (1997) Deregulated expression of cloned transcription factor E2F-1 in Chinese Hamster Ovary cells shifts protein patterns and activates growth in protein-free medium. In: Carrondo, M.J.T. et al. (Eds), Animal Cell Technology-from vaccines to genetic medicine. Kluwer Academic Publishers, pp. 621-623.
69. Ishaqe, A. and Al-Rubeai, M. (2002) Role of vitamins in determining apoptosis and extent of suppression by bcl-2 during hybridoma cell culture. Apoptosis 7:231-239.
70. Pak, S. C. O., Hunt, S.M.N., Bridges, M.W., Sleigh, M.J., and Gray, P.P. (1996) Super CHO-a cell line capable of autocrine growth under fully defined protein-free conditions. Cytotechnology 22:139-146.
71. Simpson, N.H., Singh, R. P., Emery, A. and Al-Rubeai, M. (1999) Bcl-2 overexpression reduces growth rate and prolongs G1 phase in continuous chemostat cultures of hybridoma cells. Biotechnol. Bioeng. 64:174-186.
72. Sunstrom, N.-A., S., Gay, R. D., Wong, D.C., Kitchen, N. A., Deboer, L., Gray, P.P. (2000) Insulin-like growth factor-1 and transferrin mediate growth and survival of Chinese hamster ovary cells. Biotechnol. Prog. 16:698-702.
73. Renner, W. A., Lee, K. H., Hstzimanikatis, V., Bailey, J. E., and Eppenberger (1995) Recombinant cyclin E expression activates proliferation and obviates surface attachment of Chinese hamster ovary (CHO) cells in protein-free medium. Biotechnol. Bioeng. 47:476-482.
74. Arden, N., Nivitchanyong, T., and Betenbaugh, M.J. (2004) Cell engineering blocks cell stress and improves biotherapeutic production. Bioprocess. J. 2:23-28.
75. Umaña, P., Jean-Mairet, J., Moudry, R., Amstutz, H., and Bailey, J.E. (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nature Biotechnol. 17:176-180.
76. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
77. Fussenegger, M., Morris, R. P., Fux, C., Rimann, M., von Stockar, B., Thompson, C.J., and Bailey, J.E. (2000) Streptogramin-based gene regulation systems for mammalian cells. Nature Biotechnol. 18:1203-1208.
78. Simpson, N.H., Singh, R. P., Perani, A., Goldenzon, C., and Al-Rubeai, M. (1999) In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by expression of the bcl-2 gene. Biotechnol. Bioeng. 59:90-98.
79. Mazur, X., Fussenegger, M., Renner, W. A., and Bailey, J.E. (1998) Higher productivity of growth-arrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27. Biotechnol. Prog. 14:705-713.
80. Birch, J. R., Boraston, R. C., Metcalfe, H., Brown, M.E., Bebbington, C. R. and Field, R. P. (1994) Selecting and designing cell lines for improved physiological characteristics. Cytotechnology 15:11-16.
81. Clynes, R. A., Towers, T. L., Presta, L. G., and Ravetch, J.V. (2000) Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nature Med. 6:443-446.
82. Wright, A. and Morrison, S.L. (1997) Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol. 15:26-32.
83. Bianchi, A. A. and McGrew, J.T. (2003) Highlevel expression of full-length antibodies using trans-complementing expression vectors. Biotechnol. Bioeng. 84:439-444.
84. Hunt, L., M. De Jesus, M. Jordan, and F.M. Wurm (1999) GFP expressing mammalian cells for fast, accurate, non-invasive cell growth assessment in the kinetic mode. Biotechnol. Bioeng. 65:201-205.
85. Wurm, F. M., unpublished observation.
86. Griffiths, B. and Wurm, F. (2002) Mammalian cell culture. Encycl. Phys. Sci. Technology 9:31-47.
87. Wurm, F. M., Johnson, A., Ryll, T., Köhne, C., Scherthan, H., Glaab, F., Lie, Y. S., Petropoulos, C. J., and Arathoon, W. R. (1996) Gene transfer and amplification in CHO cells. Ann. N.Y. Acad. Sci. 782:70-78.
88. Gandor, C., Leist, C., Fiechter, A., and Asselbergs, F. A. (1995) Amplification and expression of recombinant genes in serum-independent Chinese hamster ovary cells. FEBS Lett. 377:290-294.
89. Biedler, J.L. and Spengler, B.A. (1976) A novel chromosome abnormality in human neuroblastoma and antifolate-resistance Chinese hamster cell lines in culture. J. Natl. Cancer Inst. 57, 3:683-689.
90. Wurm, F. M., Gwinn, K. A., and Kingston, R. E. (1986) Inducible overexpression of the mouse c-myc protein in mammalian cells. Proc. Natl. Acad. Sci. USA 83:5414-5418.
91. Coquelle, A., Pipiras, E., Toledo, F., Buttin, G., and Debatisse, M. (1997) Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to amplicons. Cell 89:215-225.
92. Stark, G. R., Debatisse, M., Giulotto, E., and Wahl, G.M. (1989) Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57:901-908.
93. Zettlmeissl, G., Wirth, M., Hauser, H. J., and Küpper, H.A. (1988) Isolation of overproducing recombinant mammalian cells by a fast and simple selection procedure. Gene 73:419-426.
94. Wurm, F. M., unpublished observation.
95. Hendricks, M.B., Luchette, C. A., and Banker, M.J. (1989) Enhanced Expression of an immunoglobulin based vector in myeloma cells mediated by coamplification with a mutant dihydrofolate reductase gene. Biotechnology 7:1271-1274.
96. Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., and Yaranton, G.T. (1992) High level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Bio/Technology 10:169-175.
97. Barnes, L. M., Bentley, C.M. and Dickson, A. J. (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32:109-123.
98. Bebbington, C.R. (1991) Expression of antibody genes in non lymphoid mammalian cells. Methods: A companion to Methods in Enzymology 2:136-145.
99. Hsu, T. C. (1961) Chromosomal evolution in cell populations. Int. Rev. Cytol. 12:69-121.
100. Nunberg, J. H., Kaufman, R. J., Schimke, R.T., Urlaub, G., and Chasin, L. A. (1978) Amplified dihydrofolate reductase genes are localized to a homogeneously staining region of a single chromosome in a methotrexateresistant Chinese hamster ovary cell line. Proc. Natl. Acad. Sci. USA 75:5553-5556.
101. Weidle, U. H., Buckel, P. and Wienberg, J. (1988) Amplified expression constructs for human tissue-type plasminogen activator in Chinese hamster ovary cells: instability in the absence of selective pressure. Gene 66:193-203.
102. Vitek, J. A. (1987) Similarity in dynamics of single and double minute chromosomes incidence and number of chromosomal aberrations during long-term treatment of a human cell line with methotrexate. Neoplasma 34, 6:665-670.
103. Pinkel, D., Straume, T., and Gray, J.W. (1986) Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc. Natl. Acad. Sci. USA 83:2934-2938.
104. Pallavicini, M.G., DeTeresa, P. S., Rosette, C., Gray, J.W., and Wurm, F.M. (1990) Effects of Methotrexate (MTX) on Transfected DNA Stability in Mammalian Cells. Mol. Cell. Biol. 10:401-404.
105. Wurm, F. M., Pallavicini, M.G., and Arathoon, R. (1992) Integration and stability of CHO amplicons containing plasmid sequences. Dev. Biol. Stand. 76:69-82.
106. Kim, S. J. and Lee G.M. (1999) Cytogenetic analysis of chimeric antibody-producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol. Bioeng. 64, 6:741-749.
107. Van Wezel, A. L. and van der Velden-de Groot, C. A.M. (1978) Large scale cultivation of animal cells in microcarrier culture. Process Biochem. 13:6.
108. Van Wezel, A. L., van der Velden-de Groot, C. A. M., de Haan, H.H., van den Heuvel, N., and Schasfoort, R. (1984) Large scale animal cell cultivation for production of cellular biologicals. Dev. Biol. Stand. 60:229-236.
109. Berry, J. M., Barnabe, N., Coombs, K. M., and Butler, M. (1999) Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Biotechnol. Bioeng. 62(1):12-19.
110. Loumaye, E., Dreano, M., Galazka, A., Holes, C., Ham, L., Munafo, A., Eshkol, A., Giudice, E., De Luca, E., Sirna, A., Antonetti, F., Giartosio, C-E., Scaglia, L., Kelton, C., Campbell, R., Chappel, S., Duthu, B., Cymbalista, S., and Lepage, P. (1998) Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility. Hum. Reprod. Update 4, 6:862-881.
111. Spier, R. and Kadouri, A. (1997) The evolution of processes for the commercial exploitation of anchorage-dependent animal cells. Enzyme Microb. Technol. 21:2-8.
112. Wood Mackenzie, Horizons, Pharmaceuticals Issue 6 (January 2003).
113. Birch, J. R. and Arathoon, W. R. (1990) Suspension culture of mammalian cells. In: A. S. Lubiniecki (Ed) Large Scale Mammalian Cell Culture Technology. Dekker Inc. N.Y., pp. 251-270.
114. Afandi, V. and Al-Rubeai M. (2003) Stable transfection of CHO cells with the c-myc gene results in increased proliferation rates, reduces serum dependency and induces anchorage independence. Cytotechnology 41:1-10.
115. Bödecker, B.G. D., Newcomb, R., Yuan, P., Braufman, A., and Kelsey, W. (1994) Production of recombinant Factor VIII from perfusion cultures: I. Large Scale Fermentation. In: Spier, R.E., Griffiths, J.B., Berthold, W. (Eds), Animal Cell Technology, Products of Today, Prospects for Tomorrow, pp. 580-590.
116. Annual Report 1995, ARES-SERONO: Follicle Stimulating Hormone.
117. van Wedel, R. J. (1987) Mass culture of mouse and human hybridoma cells in hollow-fiber culture. In: S. Seaver (Ed) Commercial Production of Monoclonal Antibodies. Dekker, New York, pp. 159-173.
118. Davies, J. M., Lavender, C. M., Bowes, K. J., Hanak, J. A. J., Combridge B. S., and Kingsland, S. L. (1995) Human therapeutic monoclonal Anti-D antibody produced in longterm hollow-fibre culture. In: Beuvery, E.C. et al. (Eds) Animal Cell Technology: Developments towards the 21st century. Kluwer Academic Publishers, pp. 149-153.
119. Heimbuch, S. (1996) Press Release of Cellex Biosciences: Cellex Biosciences perfusion equipment used for 1st injectable product produced in hollow fiber licensed by FDA. October 30, 1996.
120. Preissmann, A., Bux, R., Schorn, P., and Noe, W. (1995) Comparative study for the propagation of anchorage-dependent cells using different forms of macroporous carriers. In: Beuvery, E.C. et al. (Eds) Animal Cell Technology: Developments towards the 21st century. Kluwer Academic Publishers, pp. 841-845.
121. Byrn, R. A., Mordenti, J., Lucas, C., Smith, D., Marsters, S. A., Johnson, J. S., Chamow, S. M., Wurm, F. M., Gregory, T., Groopman, J. E. and Capon D. J. (1990) Biological Properties of a CD4 Immunoadhesin. Nature 344, 6267:667-670.
122. Bennett, W. F., Paoni, N., Botstein, D., Jones, A. J. S., Keyt, B., Presta, L., Wurm, F.M. and Zoller M. (1991) Functional Properties of a Collection of Charged-to-Alanine Substitution Variants of Tissue-Type Plasminogen Activator. J. Biol. Chem. 266, 8:5191-5201.
123. Ostrove, J. M., Iyer, P., Marshall, J., and Vacante, D. (1998) Comparison of manufacturing techniques for Adenovirus production. In: Merten, O.W., et al. (Eds) New Developments and New Applications in Animal Cell Technology. Kluwer Academic Publishers, pp. 515-521.
124. Gorman, C. M., Gies, D.R., McCray, G. (1990) Transient Production of Proteins Using an Adenovirus Transformed Cell Line. DNA Protein Eng. Technol. 2:1-28.
125. Meissner, P., Kulangara, A., Pick, H., Chatellard, P. and Wurm, F.M. (2001) Transient Gene Expression: Recombinant Protein Production with Suspension-Adapted HEK-293EBNA Cells. Biotechnol. Bioeng. 75, 2:197-203.
126. Boussif, O., Lezoualc'h, F., Zanta, M., Mergny, M., Scheman, D., Demeneix, B., and Behr, J.-P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethyleneimine. Proc. Natl. Acad. Sci. USA 92:7297-7301.
127. Derouazi, M., Girard, P., Van Tilborgh, F., Muller, N., Bertschinger, M. and Wurm, F. M. (2004) Serum-free large scale transient transfection of CHO cells. Biotechnol. Bioeng. 84, 7:537-545.
128. Schlaeger, E. J., Legendre, J.Y., Trzeciak, A., Kitas, E. A., Christensen, K., Deuschle, U., and Supersaxo, A. (1998) Transient transfection in mammalian cells. In: Merten, O.W. et al. (Eds) New Developments and New Applications in Animal Cell Technology. Kluwer Academic Publishers. pp. 105-112.
129. Girard, P., Derouazi, M., Baumgartner, G., Bourgeois, M., Jordan, M., Jacko, B. and Wurm, F.M. (2002) 100 Liter-transient transfection. Cytotechnology 38:15-21.
130. Wurm, F.M. and Bernard, A. (2001) Transient gene expression from mammalian cells-a new chapter in animal cell technology? Cytotechnology 35:155-156.
131. Reilly, D. (Genentech), conference report 2004.
132. Batard, P., Jordan, M., Chatellard, P. and Wurm, F.M. (2001) Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene 270:61-68.
133. Hayflick, L. and Moorhead, P. S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell. Res. 25:585-621.
134. Hayflick, L. (1997) SV 40 and Human Cancer, letter. Science 276:336-337.
135. Food and Drug Administration, Center for Biologics Evaluation and Research (1987) Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals, revised 1993.
136. Wiebe, M.E. and May, L.H. (1990) Cell banking. In: Lubiniecki, A. S. (Ed) Large Scale Mammalian Cell Culture Technology. Dekker, New York, pp. 147-160.
137. Prusiner, S.B. (1997) Prion diseases and the BSE crisis. Science 278:245-251.
138. Aguzzi, A. and Polymenidou, M. (2004) Mammalian Prion Biology: One century of evolving concepts. Cell 116:313-327.
139. Wiebe, M.E., Becker, F., Lazar, R., May, L., Casto, B., Semense, M., Fautz, C., Garnick, R., Miller, C., Masover, G., Bergman, D., and Lubiniecki, A. S. (1989) A multifaceted approach to assure that recombinant tPA is free of adventitious virus. In: Spier, R. E., Griffiths, J. B., Berthold, W. (Eds) Advances in Animal Cell Biology and Technology for Bioprocesses. Croy, pp. 68-71.
140. O'Connor, J.V., Keck, R. G., Harris, R. J., and Field, M.J. (1994) In: Brown, F., Lubiniecki A. S. (Eds) Genetic Stability and Recombinant Product Consistency. Dev. Biol. Stand. Karger, Basel, pp. 165-173.
141. Garnick, R. L. (1992) Peptide mapping for detecting variants in protein products. Dev. Biol. Stand. 76:117-130.
142. Lu, H. S., Tsai, L. B., Kenney, W.C. and Lai, P.-H. (1988) Identification of unusual replacement of methionine by norleucine in recombinant interleukin-2 produced by E. coli. Biochem. Biophys. Res. Commun. 156:807-813.
143. Chloupek, R. C., Harris, R. J., Leonard, C. K., Keck, R. G., Keyt, B. A., Spellman, M.W., Jones, A. J. S., and Hancock, W. S. (1989) Study of the primary structure of recombinant tissue plasminogen activator by reversed-phase high-performance liquid chromatographic tryptic mapping. J. Chromatogr. 463:375-396.
144. O'Connor, J.V. (1993) The use of peptide mapping for the detection of heterogeneity in recombinant DNA-derived proteins. Biologicals 21:111-117.
145. Stephenson, R. C. and Clarke, S. (1989) Succinide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J. Biol. Chem. 264:6164-6170.
146. Anicetti, V. and Hancock, W. S. (1994) Analytical Considerations in the Development of Protein Purification Processes. In: R. Harrison (Ed) Protein Purification Process Engineering. Marcel Dekker, Inc., New York.
147. Calos, M., Lebkowski, J. S., and Botchan, M.R. (1983) High mutation frequency in DNA transfected into mammalian cells. Proc. Natl. Acad. Sci. USA 80:3015-3019.
148. Galibert, F. (1990) Stability of a gene recombinant: what does it mean and how to check for it. Biologicals 18:221-224.
149. Galibert, F. (1994) Assessing genetic stability at the nucleic acid level. In: Brown, F., Lubiniecki, A. S. (Eds) Genetic Stability and Recombinant Product Consistency. Dev. Biol. Stand. Karger, Basel, pp. 27-30.
150. Wurm, F. M., Petropoulos, C. J. and O'Connor, J.V. (1996) Manufacture of proteins based on recombinant CHO cells: Assessment of genetic issues and assurance of consistency and quality. In: E. R. Schmidt, Th. Hankeln (Eds) Transgenic Organisms and Biosafety-Horizontal Gene Transfer, Stability of DNA, and Expression of Transgenes. Springer, New York, pp. 283-304.
151. Drake, J.W. (1991) Spontaneous mutation. Annu. Rev. Genet. 25:125-146.
152. Harris, R. J., Murnane, A. A., Utter, S. L., Wagner, K. L., Cox, E.T., Polastri, G. D., Helder, J. C., and Sliwskowski, M.B. (1993) Assessing genetic heterogeneity in production cell lines: Detection by peptide mapping of a low level Tyr to Gln sequence variant in a recombinant antibody. Bio/Technology, pp. 1293-1297.